definiens: shall mean any pharmaceutical preparation in fina l form containing HuMax - CD20 ( or, where permitted in accordance with the provisi ons of this Agreement and, where relevant and requi red under the [ * * * ] ), for sale by prescription, over - th e - counter or any other method, or any dosage form, formulation, presentation, line extension or packag e configurations, including such Product m Developm ent where the context so requires in this Agreement, bu t excluding in all events, any [COMPANY] Product and any [COMPANY] Follow - on Product . ” 1.132 shall mean that Competing Product(s ) sold [ * * * ], when taken together, account(s ) for [ * * * ], as determined by re ference to data published in IMS, or such other publication as the JSC may agree, provided that a [ * * * ] not constitute a Competing Product for the pur poses of Significant Competition